Sign in

CIK 0001604464

  • Non-accelerated filer
  • Smaller reporting company

Atara Biotherapeutics, Inc.

Sign in to watch
Ticker
ATRA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
460920988
Phone
+1 805-623-4211
Business address
1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
Open-market buys, last 90 days
$999,994
in 1 filing
Open-market sales, last 90 days
$39,368
in 1 filing

Net +$960,625. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Cherry Brian N +$1000K Director 1 filing
  2. Nguyen AnhCo −$39K President and CEO sold 5% of stake

Reading 3 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2014-10-21 Kleiner Perkins Caufield & Byers XV, LLC 10% owner Conversion +55,314 77,621
2014-10-21 Kleiner Perkins Caufield & Byers XV, LLC 10% owner Conversion · Series A Preferred Stock −1,244,871 0
2014-10-21 Kleiner Perkins Caufield & Byers XV, LLC 10% owner Conversion · Series B Preferred Stock −607,234 0
2014-10-21 Kleiner Perkins Caufield & Byers XV, LLC 10% owner Conversion · Series A Preferred Stock −37,179 0
2014-10-21 Kleiner Perkins Caufield & Byers XV, LLC 10% owner Conversion · Series B Preferred Stock −18,136 0
2014-10-21 Gallagher Carol Giltner Director Conversion +33,475 33,475
2014-10-21 Gallagher Carol Giltner Director Purchase +18,181 $11.00 $200K 51,656
2014-10-21 Gallagher Carol Giltner Director Grant or award · Restricted Stock Unit +44,871 44,871
2014-10-21 Gallagher Carol Giltner Director Grant or award · Restricted Stock Unit +24,776 24,776
2014-10-21 Gallagher Carol Giltner Director Grant or award · Restricted Stock Unit +13,076 13,076
2014-10-21 Gallagher Carol Giltner Director Conversion · Series A Preferred Stock −22,500 0
2014-10-21 Gallagher Carol Giltner Director Conversion · Series B Preferred Stock −10,975 0
2014-10-21 Fust Matthew K Director Grant or award · Restricted Stock Unit +25,640 25,640
2014-10-21 Haqq Christopher Chief Medical Officer Grant or award · Restricted Stock Unit +13,266 13,266
2014-10-21 MCGRATH JOHN Chief Financial Officer Grant or award · Restricted Stock Unit +44,871 44,871
2014-10-21 MCGRATH JOHN Chief Financial Officer Grant or award · Restricted Stock Unit +123,158 123,158
2014-10-21 Soffer Gad Chief Operating Officer Grant or award · Restricted Stock Unit +153,846 153,846
2014-10-21 Soffer Gad Chief Operating Officer Grant or award · Restricted Stock Unit +66,332 66,332
2014-10-21 Ciechanover Isaac E. Chief Executive Officer Grant or award · Restricted Stock Unit +94,523 94,523
2014-10-21 Clark Mitchall G. Chief R & QA Officer Grant or award · Restricted Stock Unit +115,384 115,384

Page 69 of 71 · 1,403 trades